Medix Biochemica Overview

  • Founded

  • 1985

Founded
  • Status

  • Private

  • Employees

  • 300

Employees
  • Latest Deal Type

  • Buyout/​LBO

  • Financing Rounds

  • 1

  • Investments

  • 6

Medix Biochemica General Information

Description

Developer and producer of monoclonal antibodies and recombinant antigens for In Vitro Diagnostics (IVD) sectors. The company offers a wide range of reagents and ready-to-use master mixes and diagnostic tests specifically designed for the women's health sector, providing them medicines that are safe, effective and suitable for the intended use.

Contact Information

Website
www.medixbiochemica.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Primary Office
  • Klovinpellontie 3
  • 02180 Espoo
  • Finland
+358 09 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medix Biochemica Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medix Biochemica‘s full profile, request access.

Request a free trial

Medix Biochemica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and producer of monoclonal antibodies and recombinant antigens for In Vitro Diagnostics (IVD) sectors. The com
Biotechnology
Espoo, Finland
300 As of 2022
000000000000

000 00

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
0000000000000
Oxford, United Kingdom
00 As of 0000
00000
00.00 0000-00-00
000000000000 00000

000 00

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
000000000 00000 (000
Maryland Heights, MO
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medix Biochemica Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
The Native Antigen Company Private Equity-Backed Oxford, United Kingdom 00 00000 000000000000 00000
000 000000000000 Private Equity-Backed Maryland Heights, MO 000000000000
000 0000000000 Corporate Backed or Acquired San Diego, CA 000000&0
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 0000000000.
00000000 000000000 Corporation Shirley, NY
You’re viewing 5 of 7 competitors. Get the full list »

Medix Biochemica Patents

  • 64

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Medix Biochemica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3037542-A1 Method for determining risks associated with cardiovascular diseases Pending 29-Sep-2016 000000000
EP-3519819-A4 Method for determining risks associated with cardiovascular diseases Inactive 29-Sep-2016 00000000000 0
EP-3519819-A1 Method for determining risks associated with cardiovascular diseases Inactive 29-Sep-2016 000000000
US-20190234965-A1 Method for determining risks associated with cardiovascular diseases Inactive 29-Sep-2016 00000000000
EP-3110949-A4 Mmp-8 activation product, its determination and use Pending 27-Feb-2014 C12N9/64 0
To view Medix Biochemica’s complete patent history, request access »

Medix Biochemica Executive Team (8)

Name Title Board Seat Contact Info
Steve Ferguson Chief Executive Officer
Riitta Pelli Chief Financial Officer
Pamela Williams Director, Business Development
Christopher Goo Director, Operations
Ismo Råman Senior Advisor
You’re viewing 5 of 8 executive team members. Get the full list »

Medix Biochemica Board Members (6)

Name Representing Role Since
000-000000000 0000 Medix Biochemica Chairman 000 0000
000000 00000 00000 DevCo Partners Board Member 000 0000
000000 0000000 DevCo Partners Board Member 000 0000
0000000 000000000 Medix Biochemica Board Member 000 0000
00000 0000000 Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Medix Biochemica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medix Biochemica Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Medix Biochemica‘s full profile, request access.

Request a free trial

Medix Biochemica Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 0 20-Jun-2022 0000000000 Biotechnology 00000 000
000000 000000 01-Jan-2022 0000000000 Biotechnology 00000 000
00000000 13-Jul-2021 0000000000 Biotechnology 00000 000
000000000 05-Jun-2020 0000000000 Biotechnology 00000 000
EastCoast Bio 05-Jun-2020 Buyout/LBO Biotechnology 00000 000
You’re viewing 5 of 6 investments. Get the full list »

Medix Biochemica Subsidiaries (5)

Company Name Industry Location Founded
myPOLS Biotec Biotechnology Konstanz, Germany 2014
000000000 000 Biotechnology North Berwick, ME 0000
00000000 Biotechnology Besancon, France 0000
00000000000 000000 Biotechnology Weston, FL 0000
000 000000000000 Discovery Tools (Healthcare) Maryland Heights, MO 0000
To view Medix Biochemica’s complete subsidiaries history, request access »